NICE issues recommendations on bisphosphonates for treating osteoporosis
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
National Institute for Health and Care Excellence (NICE) has issued evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis.
You're leaving Univadis
We want to make sure you would like leave Univadis and follow this external link: